Autres langues Evofem Biosciences, Inc.

Actions

EVFM

US30048L3024

Marché Fermé - OTC Markets Autres places de cotation 21:59:25 15/07/2024			Varia. 5j.	Varia. 1 janv.
0,0095 ^USD	-12,04 %		-13,64 %	-85,16 %

06:01	Lupin vend ses activités commerciales américaines de santé féminine à Evofem Biosciences	MT
15/07	Evofem Bio.sciences, Inc. (OTCPK:EVFM) a acquis l'activité spécialisée dans la santé des femmes de Lupin Limited (BSE:500257) pour 84 millions de dollars.	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Lupin Sells US Commercial Women's Health Specialty Business to Evofem Biosciences	06:01
Evofem Bio.sciences, Inc. acquired Womens Health Specialty Business of Lupin Limited for $84 million.	15/07
Hello Alpha Partners with Evofem to Offer Phexxi as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare	28/06
Evofem Biosciences : Modification to Rights of Security Holders Form 8 K	26/06
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter	11/06
Evofem Biosciences Announces Financial Results for the First Quarter of 2024	15/05
Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO	18/04
Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023	27/03
Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal	20/03
Evofem Biosciences - For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy	08/03
Washington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game	08/01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI	19/12
EVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFM	18/12
North American Morning Briefing : Dow Set For New -2-	14/12
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi, the First and Only FDA-Approved Hormone-Free Contraceptive Gel	13/12
Shareholder Alert: Ademi LLP investigates whether Evofem Biosciences, Inc. has obtained a Fair Price in its transaction with Aditxt	12/12
EVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholders	12/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Evofem Biosciences, Inc.

Actions

EVFM

US30048L3024

Autres langues

Filtres